e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Novel mechanisms in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Emphysema, weight loss, atrophy of the gastrocnemius and cor pulmonale in aging IL-18 transgenic mice
H. Oda, T. Hoshino, M. Sawada, Y. Sakazaki, T. Kinoshita, T. Kawayama, H. Aizawa (Kurumeshi, Japan)
Source:
Annual Congress 2010 - Novel mechanisms in COPD
Session:
Novel mechanisms in COPD
Session type:
Thematic Poster Session
Number:
4327
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Oda, T. Hoshino, M. Sawada, Y. Sakazaki, T. Kinoshita, T. Kawayama, H. Aizawa (Kurumeshi, Japan). Emphysema, weight loss, atrophy of the gastrocnemius and cor pulmonale in aging IL-18 transgenic mice. Eur Respir J 2010; 36: Suppl. 54, 4327
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
17(R)-resolvinD1 improves MMP-9/TIMP-1 imbalance leading to amelioration of pulmonary fibrosis in mice
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
Transgenic and gene-targeted mice as models for chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 29: 375-378
Year: 2007
Relationship between the tissue depletion pattern and muscle mass, muscle strength and inflammation in COPD patients
Source: Annual Congress 2006 - COPD and systemic inflammation
Year: 2006
Treprostinil administration attenuates bleomycin-induced lung fibrosis in mice
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
A transient receptor potential melastin-2 deficiency significantly worsens the fibrotic response to bleomycin in mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype
Source: Eur Respir J, 51 (2) 1702146; 10.1183/13993003.02146-2017
Year: 2018
Increased levels of oxidative stress markers in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
Longterm NO2-exposure induces pulmonary inflammation and progressive development of airflow obstruction in C57BL/6 mice
Source: Eur Respir J 2003; 22: Suppl. 45, 196s
Year: 2003
Eosinophilic inflammation and worsening of lung function upon pirfenidone treatment in Fra-2 transgenic mice
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018
Role of dendritic cells in pulmonary fibrosis in mice
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Differences in FVC decline by extent of emphysema in patients with combined pulmonary fibrosis and emphysema (CPFE) syndrome
Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases
Year: 2015
Serum and skeletal muscle leptin in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005
Thymosin beta4 protects mice from bleomycin-induced damage in the lung
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Differential effects of emphysema on skeletal muscle fibre atrophy in hamsters
Source: Eur Respir J 2004; 23: 703-707
Year: 2004
Cardiac muscle mass and function are associated with altered body composition in patients with COPD
Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Year: 2007
Diaphragm dysfunction in combination with lung function decline is associated with higher mortality in idiopathic pulmonary fibrosis patients
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
17(R)-resolvin D1 attenuates bleomycin-induced lung fibrosis in mice
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
Quadriceps function is reduced in fibrotic idiopathic interstitial pneumonia
Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Year: 2011
Inflammatory markers in skeletal muscle of low and normal weight COPD patients
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005
Implication of microRNA-148b in chronic obstructive lung disease of betaENaC-overexpressing mice
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept